Evidence map›Paper›PMID 25301277›Full record

ArticleNeuropharmacology2015

Role of adenosine receptor subtypes in methamphetamine reward and reinforcement.

Kevin A Kavanagh, Drew C Schreiner, Sophia C Levis, Casey E O'Neill, Ryan K Bachtell

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Adenosine ACells · 2020
    Review
  4. Effects of an adenosine AJournal of psychopharmacology (Oxford, England) · 2020
    Article
  5. Review
  6. Role of dopamine DPsychopharmacology · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Purinergic Signalling: Therapeutic Developments.Frontiers in pharmacology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kevin A KavanaghDepartment of Psychology and Neuroscience and Center for Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
Drew C SchreinerDepartment of Psychology and Neuroscience and Center for Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
Sophia C LevisDepartment of Psychology and Neuroscience and Center for Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
Casey E O'NeillDepartment of Psychology and Neuroscience and Center for Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
Ryan K BachtellDepartment of Psychology and Neuroscience and Center for Neuroscience, University of Colorado Boulder, Boulder, CO, USA; Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO, USA. Electronic address: Ryan.Bachtell@Colorado.edu.
University of Colorado Boulder · US

Funding

Adenosine Receptor Involvement in Methamphetamine Reward and RelapseR01DA033358 · NIDA · UNIVERSITY OF COLORADO · PI BACHTELL, RYAN K · 2013 to 2017
$1.9M
Effects of Adenosine Signaling on Cocaine Reward and RelapseR03DA029240 · NIDA · UNIVERSITY OF COLORADO · PI BACHTELL, RYAN K · 2011 to 2012
$152k
NIDA NIH HHS DA029240NIDA NIH HHS DA 033358NIDA NIH HHS R01 DA033358NIDA NIH HHS R03 DA029240
6 · The paper itself

Abstract

The neurobiology of methamphetamine (MA) remains largely unknown despite its high abuse liability. The present series of studies explored the role of adenosine receptors on MA reward and reinforcement and identified alterations in the expression of adenosine receptors in dopamine terminal areas following MA administration in rats. We tested whether stimulating adenosine A1 or A2A receptor subtypes would influence MA-induced place preference or MA self-administration on fixed and progressive ratio schedules in male Sprague-Dawley rats. Stimulation of either adenosine A1 or A2A receptors significantly reduced the development of MA-induced place preference. Stimulating adenosine A1, but not A2A, receptors reduced MA self-administration responding. We next tested whether repeated experimenter-delivered MA administration would alter the expression of adenosine receptors in the striatal areas using immunoblotting. We observed no change in the expression of adenosine receptors. Lastly, rats were trained to self-administer MA or saline for 14 days and we detected changes in adenosine A1 and A2A receptor expression using immunoblotting. MA self-administration significantly increased adenosine A1 in the nucleus accumbens shell, caudate-putamen and prefrontal cortex. MA self-administration significantly decreased adenosine A2A receptor expression in the nucleus accumbens shell, but increased A2A receptor expression in the amygdala. These findings demonstrate that MA self-administration produces selective alterations in adenosine receptor expression in the nucleus accumbens shell and that stimulation of adenosine receptors reduces several behavioral indices of MA addiction. Together, these studies shed light onto the neurobiological alterations incurred through chronic MA use that may aid in the development of treatments for MA addiction.

Indexed as

Reinforcement, PsychologyAdenosineAdenosine A2 Receptor AgonistsAnimalsCentral Nervous System StimulantsConditioning, OperantDose-Response Relationship, DrugMaleMethamphetamineNucleus AccumbensPhenethylaminesPurinergic P1 Receptor AgonistsRatsRats, Sprague-DawleyReceptor, Adenosine A1Receptor, Adenosine A2A2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosineAdenosineAdenosine A2 Receptor AgonistsCentral Nervous System StimulantsMethamphetamineN(6)-cyclopentyladenosinePhenethylaminesPurinergic P1 Receptor AgonistsReceptor, Adenosine A1Receptor, Adenosine A2APlace conditioningPsychostimulantPurineSelf-administration

Identifiers

PMID25301277
PMCPMC4250385
OpenAlexW2093291263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.